AAAAAA

   
Results: 1-20 |
Results: 20
HEPATIC ADVANCED GLYCATION ENDPRODUCT BINDING IS INCREASED IN EXPERIMENTAL DIABETES
Authors: YOUSSEF S SOULIS T COOPER ME
Citation: S. Youssef et al., HEPATIC ADVANCED GLYCATION ENDPRODUCT BINDING IS INCREASED IN EXPERIMENTAL DIABETES, Cellular and molecular biology, 44(7), 1998, pp. 1095-1100
RENAL EXPRESSION OF TRANSFORMING-GROWTH-FACTOR-BETA INDUCIBLE GENE-H3(BETA-IG-H3) IN NORMAL AND DIABETIC RATS
Authors: GILBERT RE WILKINSONBERKA JL JOHNSON DW COX A SOULIS T WU LL KELLY DJ JERUMS G POLLOCK CA COOPER ME
Citation: Re. Gilbert et al., RENAL EXPRESSION OF TRANSFORMING-GROWTH-FACTOR-BETA INDUCIBLE GENE-H3(BETA-IG-H3) IN NORMAL AND DIABETIC RATS, Kidney international, 54(4), 1998, pp. 1052-1062
A NOVEL INHIBITOR OF ADVANCED GLYCATION END-PRODUCT FORMATION INHIBITS IN-VIVO MESENTERIC VASCULAR HYPERTROPHY IN EXPERIMENTAL DIABETES
Authors: SOULIS T SASTRA S THALLAS V MORTENSEN SB CLAUSEN JT BJERRUM OJ BOEL E COOPER ME
Citation: T. Soulis et al., A NOVEL INHIBITOR OF ADVANCED GLYCATION END-PRODUCT FORMATION INHIBITS IN-VIVO MESENTERIC VASCULAR HYPERTROPHY IN EXPERIMENTAL DIABETES, Diabetologia, 41, 1998, pp. 101-101
AMINOGUANIDINE TREATMENT INCREASES BONE-MINERAL DENSITY IN STREPTOZOTOCIN (STZ)-INDUCED DIABETIC RATS - POSSIBLE ROLE OF AGE FORMATION
Authors: KATAYAMA Y SOULIS T COOPER ME SEEMAN E NAGATA N MARTIN TJ FINDLAY DM
Citation: Y. Katayama et al., AMINOGUANIDINE TREATMENT INCREASES BONE-MINERAL DENSITY IN STREPTOZOTOCIN (STZ)-INDUCED DIABETIC RATS - POSSIBLE ROLE OF AGE FORMATION, Journal of bone and mineral research, 12, 1997, pp. 650-650
BINDING AND QUANTITATION OF ADVANCED GLYCATION END-PRODUCTS (AGES) AND RECEPTOR FOR AGES (RAGE) IN THE DIABETIC RAT-KIDNEY
Authors: SOULIS T YOUSSEF S THALLAS V COOPER ME
Citation: T. Soulis et al., BINDING AND QUANTITATION OF ADVANCED GLYCATION END-PRODUCTS (AGES) AND RECEPTOR FOR AGES (RAGE) IN THE DIABETIC RAT-KIDNEY, Kidney international, 51(4), 1997, pp. 1314-1315
VASCULAR HYPERTROPHY IN EXPERIMENTAL DIABETES - ROLE OF ADVANCED GLYCATION END-PRODUCTS
Authors: RUMBLE JR COOPER ME SOULIS T COX A WU L YOUSSEF S JASIK M JERUMS G GILBERT RE
Citation: Jr. Rumble et al., VASCULAR HYPERTROPHY IN EXPERIMENTAL DIABETES - ROLE OF ADVANCED GLYCATION END-PRODUCTS, The Journal of clinical investigation, 99(5), 1997, pp. 1016-1027
ADVANCED GLYCATION END-PRODUCTS AND THEIR RECEPTORS CO-LOCALIZE IN RAT ORGANS SUSCEPTIBLE TO DIABETIC MICROVASCULAR INJURY
Authors: SOULIS T THALLAS V YOUSSEF S GILBERT RE MCWILLIAM BG MURRAYMCINTOSH RP COOPER ME
Citation: T. Soulis et al., ADVANCED GLYCATION END-PRODUCTS AND THEIR RECEPTORS CO-LOCALIZE IN RAT ORGANS SUSCEPTIBLE TO DIABETIC MICROVASCULAR INJURY, Diabetologia, 40(6), 1997, pp. 619-628
RELATIVE CONTRIBUTIONS OF ADVANCED GLYCATION AND NITRIC-OXIDE SYNTHASE INHIBITION TO AMINOGUANIDINE-MEDIATED RENOPROTECTION IN DIABETIC RATS
Authors: SOULIS T COOPER ME SASTRA S THALLAS V PANAGIOTOPOULOS S BJERRUM OJ JERUMS G
Citation: T. Soulis et al., RELATIVE CONTRIBUTIONS OF ADVANCED GLYCATION AND NITRIC-OXIDE SYNTHASE INHIBITION TO AMINOGUANIDINE-MEDIATED RENOPROTECTION IN DIABETIC RATS, Diabetologia, 40(10), 1997, pp. 1141-1151
REPORT ON THE THIRD EASD SCIENTISTS TRAINING COURSE
Authors: NEOPHYTOU P WEYER C LUPPI P JORNS A BOTTINO R CAMPBELLTOFTE J COHEN O GURNIAK M HUOTARI MA JENSEN P KARLSSON M LEFEBVRE V MABLEY J MORGENTHALER N MUELLER R OHARTE F RUDICH A SOULIS T UTRIAINEN T
Citation: P. Neophytou et al., REPORT ON THE THIRD EASD SCIENTISTS TRAINING COURSE, Diabetologia, 40(1), 1997, pp. 1-2
PREVENTION OF THE DEPLETION OF NITRIC-OXIDE SYNTHASE CONTAINING NEURONS IN THE DIABETIC RAT BY AMINOGUANIDINE
Authors: SOULIS T ROUFAIL E COOPER ME REES SM
Citation: T. Soulis et al., PREVENTION OF THE DEPLETION OF NITRIC-OXIDE SYNTHASE CONTAINING NEURONS IN THE DIABETIC RAT BY AMINOGUANIDINE, Diabetologia, 40, 1997, pp. 1938-1938
AMINOGUANIDINE TREATMENT INCREASES BONE-MINERAL DENSITY IN STZ INDUCED DIABETIC RATS
Authors: KATAYAMA Y SOULIS T COOPER ME SEEMAN E NAGATA N MARTIN TJ FINDLAY DM
Citation: Y. Katayama et al., AMINOGUANIDINE TREATMENT INCREASES BONE-MINERAL DENSITY IN STZ INDUCED DIABETIC RATS, Diabetologia, 40, 1997, pp. 2289-2289
AMINOGUANIDINE PREVENTS RETINAL BUT NOT GLOMERULAR CAPILLARY BASEMENT-MEMBRANE THICKENING IN EXPERIMENTAL DIABETES
Authors: MAO CS CARROLL N PANAGIOTOPOULOS S SOULIS T JOON TL COOPER ME JERUMS G TAYLOR H
Citation: Cs. Mao et al., AMINOGUANIDINE PREVENTS RETINAL BUT NOT GLOMERULAR CAPILLARY BASEMENT-MEMBRANE THICKENING IN EXPERIMENTAL DIABETES, Investigative ophthalmology & visual science, 37(3), 1996, pp. 4446-4446
ADVANCED GLYCATION IS AN IMPORTANT PATHOGENIC PROCESS IN EXPERIMENTALDIABETIC NEPHROPATHY
Authors: SOULIS T SASTRA S THALLAS V BERKA J MCWILLIAM B MURRAYMCINTOSH RP GILBERT R NEALE TJ JERUMS G COOPER ME
Citation: T. Soulis et al., ADVANCED GLYCATION IS AN IMPORTANT PATHOGENIC PROCESS IN EXPERIMENTALDIABETIC NEPHROPATHY, Kidney international, 50(4), 1996, pp. 1415-1415
EFFECTS OF AMINOGUANIDINE IN PREVENTING EXPERIMENTAL DIABETIC NEPHROPATHY ARE RELATED TO THE DURATION OF TREATMENT
Authors: SOULIS T COOPER ME VRANES D BUCALA R JERUMS G
Citation: T. Soulis et al., EFFECTS OF AMINOGUANIDINE IN PREVENTING EXPERIMENTAL DIABETIC NEPHROPATHY ARE RELATED TO THE DURATION OF TREATMENT, Kidney international, 50(2), 1996, pp. 627-634
ADVANCED GLYCATION ENDPRODUCT BINDING IN THE DIABETIC RAT-KIDNEY
Authors: YOUSSEF S SOULIS T COOPER ME
Citation: S. Youssef et al., ADVANCED GLYCATION ENDPRODUCT BINDING IN THE DIABETIC RAT-KIDNEY, Diabetologia, 39, 1996, pp. 81-81
AMINOGUANIDINE ATTENUATES MESENTERIC VASCULAR HYPERTROPHY AND TGF-BETA-1 MESSENGER-RNA IN DIABETIC RATS
Authors: RUMBLE JR COOPER ME SOULIS T COX A JASIK M JERUMS G GILBERT RE
Citation: Jr. Rumble et al., AMINOGUANIDINE ATTENUATES MESENTERIC VASCULAR HYPERTROPHY AND TGF-BETA-1 MESSENGER-RNA IN DIABETIC RATS, Diabetologia, 39, 1996, pp. 259-259
OCULAR AND RENAL EFFECTS OF AMINOGUANIDINE, PERINDOPRIL AND LACIDIPINE ON VASCULAR-PERMEABILITY IN EXPERIMENTAL DIABETES
Authors: PANAGIOTOPOULOS S JERUMS G LIMJOON T LEE V GIN T COHEN N SOULIS T TAYLOR H
Citation: S. Panagiotopoulos et al., OCULAR AND RENAL EFFECTS OF AMINOGUANIDINE, PERINDOPRIL AND LACIDIPINE ON VASCULAR-PERMEABILITY IN EXPERIMENTAL DIABETES, Diabetologia, 39, 1996, pp. 1166-1166
AMINOGUANIDINE ATTENUATES MESENTERIC VASCULAR HYPERTROPHY AND GENE-EXPRESSION OF TGF-BETA-1 AND TYPE-IV COLLAGEN IN EXPERIMENTAL DIABETES
Authors: RUMBLE J COOPER M SOULIS T COX A JASIK M JERUMS G GILBERT R
Citation: J. Rumble et al., AMINOGUANIDINE ATTENUATES MESENTERIC VASCULAR HYPERTROPHY AND GENE-EXPRESSION OF TGF-BETA-1 AND TYPE-IV COLLAGEN IN EXPERIMENTAL DIABETES, Diabetes, 45, 1996, pp. 167-167
ARE THE RENOPROTECTIVE EFFECTS OF AMINOGUANIDINE IN DIABETES MEDIATEDVIA ITS ACTION AS AN NO SYNTHASE INHIBITOR
Authors: SOULIS T COOPER ME SASTRA S PANAGIOTOPOULOS S JERUMS G
Citation: T. Soulis et al., ARE THE RENOPROTECTIVE EFFECTS OF AMINOGUANIDINE IN DIABETES MEDIATEDVIA ITS ACTION AS AN NO SYNTHASE INHIBITOR, Diabetologia, 38, 1995, pp. 47-47
AMINOGUANIDINE AND METHYLGUANIDINE REDUCES MESENTERIC VASCULAR ENLARGEMENT IN EXPERIMENTAL DIABETES
Authors: NGUYEN DT PANAGIOTOPOULOS S SOULIS T COOPER ME JERUMS G
Citation: Dt. Nguyen et al., AMINOGUANIDINE AND METHYLGUANIDINE REDUCES MESENTERIC VASCULAR ENLARGEMENT IN EXPERIMENTAL DIABETES, Diabetologia, 38, 1995, pp. 255-255
Risultati: 1-20 |